Literature DB >> 23796480

Adderall® (amphetamine-dextroamphetamine) toxicity.

Kevin T Fitzgerald1, Alvin C Bronstein.   

Abstract

The American Psychiatric Association estimates that 3-7% of US school-aged children exhibit attention-deficit/hyperactivity disorder (ADHD). Adderall(®) (amphetamine dextroamphetamine) and a variety of brand names and generic versions of this combination are available by prescription to treat ADHD and narcolepsy. Both immediate and sustained release products are used as are single agent amphetamine medication. Knowing the exact agent ingested can provide information of dose labeled and length of clinical effects. These drugs are used off label by college students for memory enhancement, test taking ability, and for study marathons. These agents are DEA Schedule II controlled substances with high potential for abuse. For humans with ADHD or narcolepsy, standard recommended dosage is 5-60 mg daily. Amphetamine and its analogues stimulate the release of norepinephrine affecting both α- and β-adrenergic receptor sites. α-Adrenergic stimulation causes vasoconstriction and an increase in total peripheral resistance. β-Adrenergic receptor stimulation leads to an increase in heart rate, stroke volume, and skeletal muscle blood flow. Clinical signs of Adderall(®) overdose in humans and dogs include hyperactivity, hyperthermia, tachycardia, tachypnea, mydriasis, tremors, and seizures. In addition, Adderall intoxication in dogs has been reported to cause hyperthermia, hypoglycemia, hypersegmentation of neutrophils, and mild thrombocytopenia. Diagnosis can be confirmed by detecting amphetamine in stomach contents or vomitus, or by positive results obtained in urine tests for illicit drugs. Treatment is directed at controlling life-threatening central nervous system and cardiovascular signs. Seizures can be controlled with benzodiazepines, phenothiazines, pentobarbital, and propofol. Cardiac tachyarrhythmias can be managed with a β-blocker such as propranolol. Intravenous fluids counter the hyperthermia, assist in maintenance of renal function, and help promote the elimination of amphetamine and its analogues. Prognosis after poisoning with Adderall(®) depends upon the severity and duration of clinical signs at presentation. Differential diagnoses that should be considered in cases of suspected amphetamine overdose are any other agents that can cause central nervous system stimulation, tremors, and seizures. This article discusses our present understanding of Adderall(®) intoxication and examines 3 dogs presented to our practice after ingestion of large amounts of the drug.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23796480     DOI: 10.1053/j.tcam.2013.03.002

Source DB:  PubMed          Journal:  Top Companion Anim Med        ISSN: 1946-9837


  11 in total

Review 1.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

2.  Discordant reporting of nonmedical amphetamine use among Adderall-using high school seniors in the US.

Authors:  Joseph J Palamar; Austin Le
Journal:  Drug Alcohol Depend       Date:  2017-10-20       Impact factor: 4.492

Review 3.  Wake-promoting pharmacotherapy for psychiatric disorders.

Authors:  Bernardo Dell'Osso; Cristina Dobrea; Laura Cremaschi; Chiara Arici; A Carlo Altamura
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

4.  Amphetamine enhances endurance by increasing heat dissipation.

Authors:  Ekaterina Morozova; Yeonjoo Yoo; Abolhassan Behrouzvaziri; Maria Zaretskaia; Daniel Rusyniak; Dmitry Zaretsky; Yaroslav Molkov
Journal:  Physiol Rep       Date:  2016-09

5.  Takotsubo Syndrome: Clinical Manifestations, Etiology and Pathogenesis.

Authors:  Ekaterina S Prokudina; Boris K Kurbatov; Konstantin V Zavadovsky; Alexander V Vrublevsky; Natalia V Naryzhnaya; Yuri B Lishmanov; Leonid N Maslov; Peter R Oeltgen
Journal:  Curr Cardiol Rev       Date:  2021

6.  Association of leukocytosis with amphetamine and cocaine use.

Authors:  John R Richards; Valeria F Farias; Chris S Clingan
Journal:  ScientificWorldJournal       Date:  2014-01-22

7.  Methamphetamine intoxication in a dog: case report.

Authors:  Zengyang Pei; Xu Zhang
Journal:  BMC Vet Res       Date:  2014-06-24       Impact factor: 2.741

8.  No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination.

Authors:  Favelle Lamb; Alexander Ploner; Katharina Fink; Markus Maeurer; Peter Bergman; Fredrik Piehl; Daniel Weibel; Pär Sparén; Lisen Arnheim Dahlström
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

9.  Brain doping: stimulants use and misuse among a sample of Italian college students.

Authors:  S Majori; D Gazzani; S Pilati; J Paiano; A Sannino; S Ferrari; E Checchin
Journal:  J Prev Med Hyg       Date:  2017-06

10.  Severe Rhabdomyolysis Associated with Acute Amphetamine Toxicosis in a Dog.

Authors:  M Ryan Smith; Virginie A Wurlod
Journal:  Case Rep Vet Med       Date:  2020-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.